ImCyse (Belgium)

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes

Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al. · BMC Medicine · 2023 · 27 citations · Full text

Life Sciences, Endocrinology, Immunology +17

Thioreductase-Containing Epitopes Inhibit the Development of Type 1 Diabetes in the NOD Mouse Model

Elin Malek Abrahimians, Luc Vander Elst, Vincent Carlier et al. · Frontiers in Immunology · 2016 · 21 citations · Full text

Life Sciences, Immunology, Pathobiology +17

A future of AI-driven personalized care for people with multiple sclerosis

Jelle Praet, Lina Anderhalten, Dana Horáková et al. · Frontiers in Immunology · 2024 · 21 citations · Full text

Life Sciences, Immunology, Neurology +14

First-in-human, double-blind, randomized phase 1b study of peptide immunotherapy IMCY-0098 in new-onset type 1 diabetes: an exploratory analysis of immune biomarkers

Jean Van Rampelbergh, Peter Achenbach, Richard David Leslie et al. · BMC Medicine · 2024 · 16 citations · Full text

Life Sciences, Immunology, Pharmacology +17